aspirin and glp-1 drugs colorectal cancer prevention Glucagon-like peptide-1 receptor agonist therapy

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression

Achieve Sustainable Results With Personalized Care.

However, no direct link has been found between GLP-1R agonists and higher pulmonary aspiration risk

Wegovy debate

The GLP-Squared Protocol from PlexusDx is a compounded dual-compound GLP-1 formulation combining Semaglutide and Tirzepatide, prescribed by licensed providers as a clinical step-up

Inflammatory bowel diseases (IBD), including Crohns disease (CD) and ulcerative colitis (UC), are chronic, relapsing, intestinal inflammatory disorders with complex and yet unrevealed pathogenesis in which genetic, immunological, and environmental factors play a role